共 50 条
- [41] Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing DataDigestive Diseases and Sciences, 2022, 67 : 4382 - 4386Colin W. HowdenKely L. SheldonJune S. AlmenoffWilliam D. Chey
- [42] The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance studyCardiovascular Diabetology, 22Adam GoldmanBoris FishmanGilad TwigEmanuel RaschiTali Cukierman-YaffeYonatan moshkovitsAlon PomerantzIlan Ben-ZviRachel DanknerElad Maor
- [43] The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance studyCARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)Goldman, AdamFishman, BorisTwig, GiladRaschi, EmanuelCukierman-Yaffe, TaliMoshkovits, YonatanPomerantz, AlonBen-Zvi, IlanDankner, RachelMaor, Elad
- [44] Current status and time trends of lipid and use of statins among older adults in China-real world data from primary community health institutionsFRONTIERS IN PUBLIC HEALTH, 2023, 11Jiang, JunrongHuang, JunDeng, HaiLiao, HongtaoFang, XianhongZhan, XianzhangWu, ShulinXue, Yumei
- [45] New data show that people with type 2 diabetes initiated on Forxiga®. (dapagliflozin) in UK real-world practice achieve results consistent with clinical trialsDIABETES OBESITY & METABOLISM, 2015, 17 (11): : 1106 - 1106Idris, Iskandar
- [46] Pitfalls of Physician-Directed Treatment of H. pylori Infection: Results From Two Phase 3 Clinical Trials and Real-World Prescribing DataAMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S665 - S665Howden, ColinSheldon, Kely L.Almenoff, June S.Chey, William D.
- [47] Detecting deviations from the efficacy and safety results of single-arm trials using real-world data: The case of a CAR-T cell therapy in B-cell lymphomaPHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (04) : 514 - 519Jakobsen, Lasse HjortCallreus, TorbjornSessa, MaurizioJerkeman, MatsAndersen, MortenEl-Galaly, Tarec Christoffer
- [48] Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World ExperienceJOURNAL OF INFECTIOUS DISEASES, 2022, 225 (05): : 785 - 792Gilboa, MayanMandelboim, MichalIndenbaum, VictoriaLustig, YanivCohen, CarmitRahav, GaliaAsraf, KerenAmit, SharonJaber, HanaaNemet, ItalKliker, LimorBar-Haim, ErezMendelson, EllaDoolman, RamRubin, CarmitRegev-Yochay, GiliKreiss, Yitshak
- [49] A French Multicentric Prospective Cohort of 6000 Patients with Integrative Epidemiological, Clinical, Biological and Treatment Data to Improve Knowledge on Outcome of Lymphoma Patients: Pilot Phase Results of the Real World Data in Lymphoma and Survival in Adults (REALYSA) StudyBLOOD, 2019, 134Ghesquieres, HerveRossi, CedricCherblanc, FannyLe Guyader, SandraBijou, FontanetSujobert, PierreFabbro-Peray, PascaleFornecker, Luc MathieuBernier, AdelineBaldi, IsabelleBouabdallah, KrimoLaurent, CamilleOberic, LucieMorineau, NadineSalles, Gilles A.Ysebaert, LoicMonnereau, Alain
- [50] FROM CLINICAL TRIALS TO REAL-WORLD EVIDENCE: SIMILAR VIROLOGIC CURE RATES AND SAFETY OUTCOMES FOLLOWING TREATMENT WITH GLECAPREVIR/PIBRENTASVIR AMONG PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT DRUG USEHEPATOLOGY, 2019, 70 : 932A - 933AAghemo, AlessioNegro, FrancescoGschwantler, MichaelAsselah, TarikBondin, Mark I.Crown, Eric D.Mancine, MikiZhang, ZhenzhenFlisiak, RobertGrebely, JasonBrau, NorbertSterling, Richard K.